📣 VC round data is live. Check it out!

Extendicare Valuation Multiples

Discover Extendicare's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Attendo, Clariane, Addus HomeCare, Sienna Senior Living and more.

Extendicare Overview

About Extendicare

Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.


Founded

2012

HQ

Canada

Employees

24.0K

Financials (LTM)

Revenue: $1B
EBITDA: $151M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Extendicare Financials

Extendicare reported last 12-month revenue of $1B and EBITDA of $151M.

In the same LTM period, Extendicare generated $151M in EBITDA and $84M in net income.

Revenue (LTM)


Extendicare P&L

In the most recent fiscal year, Extendicare reported revenue of $1B and EBITDA of $135M.

Extendicare is profitable as of last fiscal year, with EBITDA margin of 11% and net margin of 6%.

See analyst estimates for Extendicare
LTMLast FY202320242025202620272028
Revenue$1B$1B$946M$1B$1B
EBITDA$151M$135M$71M$112M$135M
EBITDA Margin11%11%8%11%11%
EBIT Margin-8%5%8%8%
Net Profit$84M$71M$25M$55M$70M
Net Margin6%6%3%5%6%

Financial data powered by Morningstar, Inc.

Extendicare Stock Performance

Extendicare has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Extendicare's stock price is $22.19.

Extendicare share price decreased by 5.6% in the last 30 days, and increased by 114.8% in the last year.

Extendicare has an EPS (earnings per share) of $0.75.

See more trading valuation data for Extendicare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-5.6%-5.6%15.8%114.8%$0.75

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Extendicare Valuation Multiples

Extendicare trades at 1.5x EV/Revenue multiple, and 13.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Extendicare

EV / Revenue (LTM)


Extendicare Financial Valuation Multiples

As of June 2, 2026, Extendicare has market cap of $2B and EV of $2B.

Extendicare has a P/E ratio of 25.2x.

LTMLast FY202320242025202620272028
EV/Revenue1.5x1.7x2.2x2.0x1.8x
EV/EBITDA13.9x15.6x29.5x18.8x15.6x
EV/EBIT-21.0x46.2x26.1x21.0x
P/E25.2x29.7x85.4x38.6x30.0x
EV/FCF80.2x28.0x(27.4x)28.6x28.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Extendicare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Extendicare Margins & Growth Rates

Extendicare grew revenue by 33% and EBITDA by 35% in the last fiscal year.

In the most recent fiscal year, Extendicare reported EBITDA margin of 11% and net margin of 6%.

See estimated margins and future growth rates for Extendicare

Extendicare Margins

Last FY202420252026202720282029
EBITDA Margin11%11%11%11%
EBIT Margin8%8%8%-
Net Margin6%5%6%6%
FCF Margin6%7%6%(2%)

Extendicare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth33%12%13%35%
EBITDA Growth35%57%21%35%
EBIT Growth-77%25%-
Net Profit Growth43%121%29%45%
FCF Growth(152%)(196%)2%(152%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Extendicare Operational KPIs

Extendicare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Extendicare's Rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Extendicare's Rule of X is 99% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Extendicare
LTMLast FY202320242025202620272028
Rule of 4033%46%---
Bessemer Rule of X65%99%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue3%81%83%82%82%
Opex to Revenue-91%95%92%92%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Extendicare Competitors

Extendicare competitors include Attendo, Clariane, Addus HomeCare, Sienna Senior Living, Sonida Senior Living, Aveanna Healthcare, Emeis, Regis Healthcare, National Healthcare Corp and Ryman Healthcare.

Most Extendicare public comparables operate across Long-Term Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Attendo1.6x1.7x8.1x8.1x
Clariane1.6x1.6x7.4x7.8x
Addus HomeCare1.2x1.2x9.5x9.2x
Sienna Senior Living3.3x3.2x21.1x19.3x
Sonida Senior Living8.1x6.3x57.5x34.8x
Aveanna Healthcare1.1x1.1x8.3x8.5x
Emeis1.8x1.8x12.8x12.3x
Regis Healthcare3.5x3.0x16.8x30.4x

This data is available for Pro users. Sign up to see all Extendicare competitors and their valuation data.

Start Free Trial

Extendicare VC Funding History

Before going public, Extendicare raised $100K in total equity funding, across 1 round.


Extendicare Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-20Secondary - publicSandpiper Group$100K--

Acquisitions by Extendicare

Extendicare has acquired 1 company to date.

Last acquisition by Extendicare was on April 30th 2015. Extendicare acquired Revera (home health unit) for $61M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Extendicare

Revera (home health unit)
Description
Revera Home Health is a provider of in-home care services for seniors, including personal support, nursing, companionship, and therapy. It operates across Canada with tailored programs for aging in place. Winnipeg, Manitoba-headquartered Revera delivers services through local teams in provinces such as Ontario, British Columbia, and Alberta.
HQ CountryCanada
HQ City
Toronto
Deal Date30 Apr 2015
Valuation$61M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Extendicare acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Extendicare

When was Extendicare founded?Extendicare was founded in 2012.
Where is Extendicare headquartered?Extendicare is headquartered in Canada.
How many employees does Extendicare have?As of today, Extendicare has over 24K employees.
Who is the CEO of Extendicare?Extendicare's CEO is Michael R. Guerriere.
Is Extendicare publicly listed?Yes, Extendicare is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Extendicare?Extendicare trades under EXE ticker.
When did Extendicare go public?Extendicare went public in 1974.
Who are competitors of Extendicare?Extendicare main competitors include Attendo, Clariane, Addus HomeCare, Sienna Senior Living, Sonida Senior Living, Aveanna Healthcare, Emeis, Regis Healthcare, National Healthcare Corp, Ryman Healthcare.
What is the current market cap of Extendicare?Extendicare's current market cap is $2B.
What is the current revenue of Extendicare?Extendicare's last 12 months revenue is $1B.
What is the current revenue growth of Extendicare?Extendicare revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Extendicare?Current revenue multiple of Extendicare is 1.5x.
What is the current EBITDA of Extendicare?Extendicare's last 12 months EBITDA is $151M.
What is Extendicare's EBITDA margin?Extendicare's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of Extendicare?Current EBITDA multiple of Extendicare is 13.9x.
What is the current FCF of Extendicare?Extendicare's last 12 months FCF is $26M.
What is Extendicare's FCF margin?Extendicare's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Extendicare?Current FCF multiple of Extendicare is 80.2x.
How many companies Extendicare has acquired to date?As of June 2026, Extendicare has acquired 1 company.
What was the largest acquisition by Extendicare?$61M acquisition of Revera (home health unit) on 30th April 2015 was the largest M&A Extendicare has done to date.
What companies Extendicare acquired?Extendicare acquired Revera (home health unit).
In how many companies Extendicare has invested to date?Extendicare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Extendicare

Lists including Extendicare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial